ID Source | ID |
---|---|
PubMed CID | 535289 |
CHEBI ID | 24559 |
SCHEMBL ID | 2681932 |
MeSH ID | M0495335 |
Synonym |
---|
5755-27-1 |
1,3-dinitro-5-nitroso-1,3,5-triazinane |
hexahydro-1-nitroso-3,5-dinitro-1,3,5-triazine |
CHEBI:24559 |
s-triazine, hexahydro-1,3-dinitro-5-nitroso- |
ccris 9501 |
SCHEMBL2681932 |
LOSVOOKTCVILPF-UHFFFAOYSA-N |
1,3-dinitro-5-nitroso-1,3,5-triazinane # |
1-nitroso-3,5-dinitro-hexahydro-1,3,5-triazine |
Q27109845 |
Excerpt | Reference | Relevance |
---|---|---|
" LC20 and LC50 for TNX were slightly lower than for MNX; this indicates that TNX was more toxic than MNX." | ( Toxicity of the explosive metabolites hexahydro-1,3,5-trinitroso-1,3,5-triazine (TNX) and hexahydro-1-nitroso-3,5-dinitro-1,3,5-triazine (MNX) to the earthworm Eisenia fetida. Anderson, TA; Kendall, RJ; Zhang, B, 2006) | 0.55 |
Excerpt | Reference | Relevance |
---|---|---|
"The uptake kinetics of two major RDX (hexahydro-1,3,5-trinitro-1,3,5-triazacyclohexane) metabolites, hexahydro-1-nitroso-3,5-dinitro-1,3,5-triazine (MNX) and hexahydro-1,3,5-trinitroso-1,3,5-triazine (TNX), into passive sampling devices (PSDs), and the ability of PSDs to serve as surrogates for evaluating bioavailability of MNX and TNX were investigated in laboratory sand and two soil types." | ( Evaluating the bioavailability of explosive metabolites, hexahydro-1-nitroso-3,5-dinitro-1,3,5-triazine (MNX) and hexahydro-1,3,5-trinitroso-1,3,5-triazine (TNX), in soils using passive sampling devices. Anderson, TA; Smith, PN; Zhang, B, 2006) | 0.79 |
Class | Description |
---|---|
1,3,5-triazinanes | |
N-nitro compound | A compound having the nitro group (-NO2) attached to a nitrogen atom. |
nitrosamine | N-Nitroso amines, compounds of the structure R2NNO. Compounds RNHNO are not ordinarily isolable, but they, too, are nitrosamines. The name is a contraction of N-nitrosoamine and, as such, does not require the N locant. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (44.44) | 29.6817 |
2010's | 5 (55.56) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.15) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 9 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |